Autolus Therapeutics plc
AUTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $599,628 | $1,120,186 | $180,487 | $374,116 |
| - Cash | $227,380 | $239,566 | $382,436 | $310,338 |
| + Debt | $297,229 | $52,967 | $24,256 | $20,998 |
| Enterprise Value | $669,477 | $933,587 | -$177,693 | $84,776 |
| Revenue | $10,120 | $1,698 | $6,194 | $1,507 |
| % Growth | 496% | -72.6% | 311% | – |
| Gross Profit | -$130,900 | $1,698 | $6,194 | $1,507 |
| % Margin | -1,293.5% | 100% | 100% | 100% |
| EBITDA | -$233,073 | -$156,770 | -$132,240 | -$132,475 |
| % Margin | -2,303.1% | -9,232.6% | -2,135% | -8,790.6% |
| Net Income | -$220,662 | -$208,383 | -$148,839 | -$142,096 |
| % Margin | -2,180.5% | -12,272.3% | -2,403% | -9,429.1% |
| EPS Diluted | -0.87 | -1.2 | -1.57 | -1.97 |
| % Growth | 27.5% | 23.6% | 20.3% | – |
| Operating Cash Flow | -$206,271 | -$145,587 | -$112,308 | -$117,861 |
| Capital Expenditures | -$34,819 | -$10,986 | -$10,841 | -$8,857 |
| Free Cash Flow | -$241,090 | -$156,573 | -$123,149 | -$126,718 |